Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

This field is for validation purposes and should be left unchanged.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Sort 552 results by:

Filter Applied. Clear All
Reset All Filters

Search Results for: chemical abortion

How the Legal Status of Abortion Impacts Abortion Rates

Arguments that legalizing abortion will improve various public health outcomes has been a frequent talking point in various political efforts to either legalize abortion or liberalize abortion laws around the world. However, an extremely broad body of economic and public health research clearly indi...

Abortion Reporting: Utah (2016)

In a CLI study of state abortion reporting, Utah’s reports ranked in the top ten among the 50 states, the District of Columbia, and New York City. Still, the state has room for improvement. Utah could release its reports more quickly – 36 states published their 2016 reports before Utah did, and ...

Analysis: FDA Decision Ignores Data on Complications, Puts Women at Risk

As a dangerous drug, mifepristone has been subject to regulations put in place by the Food and Drug Administration (FDA) in 2000.[1] Under these regulations, called a Risk Evaluation and Mitigation Strategy (REMS), mifepristone may only be dispensed in person by certain qualified medical providers.

Abortion Reporting: Louisiana (2021)

Louisiana’s 2021 abortion report was published by the Louisiana Department of Health in June 2023. The data published on the Department’s website is marked as preliminary, but CLI was able to confirm via email correspondence with Department officials that the data is final. The report shows that...

Gestational Limits on Abortion in the United States Compared to International Norms (April 2024)

This report compares gestational limits on abortion in the U.S. with limits in other countries and serves as an update to CLI's original 2014 study. Of 193 U.N. countries, the U.S. is one of eight countries that allows, at the federal level, abortion on demand without any gestational limits. The U.S...

Sex-Selection Abortion: The Real War on Women

Despite advances in civil rights and the recognition by most developed nations that discrimination on the basis of sex alone is inherently unjust, a very real and pervasive form of sex discrimination is still permitted and practiced in the world today. Prenatal sex discrimination crosses cultural, e...

The Women’s Health Protection Act of 2023: Attacking the Health and Freedom of Women

On March 8, 2023, Senator Tammy Baldwin (D-WI) introduced the latest version of the pro-abortion “Women’s Health Protection Act” (S. 701).

U.S. Abortion Trends: 2021-2022

This paper is an analysis of 2021 and 2022 abortion data published by state health departments, along with a discussion of recent estimates for 2023. Of the 34 states that reported abortion data for both 2021 and 2022 as of April 2024, there was a 4% overall decrease in the number of abortions.